Published: 21 December 2021
Author(s): José Miguel Rivera-Caravaca, Wern Yew Ding, Francisco Marín, Vanessa Roldán, Gregory Y.H. Lip, Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc
Issue: April 2022
Section: Letter to the Editor

The CHA2DS2-VASc score is one of the most validated risk tools in atrial fibrillation (AF) [1], and remains a simple and practical clinical score to aid decision-making. However, it has limitations in predicting the absolute stroke risk and its ability for identifying patients at risk of thromboembolism is modest.

Newsletters

Stay informed on our latest news!